LICENSE AND COMMERCIALIZATION AGREEMENTLicense and Commercialization Agreement • November 1st, 2022 • Harmony Biosciences Holdings, Inc. • Pharmaceutical preparations • England and Wales
THIS LICENSE AND COMMERCIALIZATION AGREEMENT (“Agreement”) dated as of July 31, 2022 (“Signing Date”) is entered into between Bioprojet Société Civile de Recherche, an independent (privately owned) research company organized under the laws of France and having its principal place of business at 30, rue des Francs-Bourgeois, 75003 Paris, France (together with its Affiliates, including Bioprojet Pharma SAS and Bioprojet Europe Ltd., “Bioprojet”) and Harmony Biosciences, LLC, a limited liability company organized under the laws of Delaware and having its principal place of business at 630 W. Germantown Pike, Suite 215, Plymouth Meeting, Pennsylvania, USA (“Harmony”).
AMENDMENT NO. 1 TO CREDIT AGREEMENTCredit Agreement • November 1st, 2022 • Harmony Biosciences Holdings, Inc. • Pharmaceutical preparations • New York
